Transcend Therapeutics
Organization in Medicine
Transcend Therapeutics has come up in 1 episode across 1 podcast in TMT, including The Tim Ferriss Show. 1 person has made recorded remarks about it.
What people said
Kevin RyanAmerican entrepreneur and investor, founder and CEO of AlleyCorp and former CEO of DoubleClick
Ryan says the high cost of FDA approval is why psychedelic development needed a for-profit company rather than philanthropy alone.
“it takes roughly $200 to $250 million to get one compound through the FDA process”
The Tim Ferriss Show: #884: How to Spot 10-Year Trends and Build Billion-Dollar Companies — Kevin Ryan of DoubleClick, MongoDB, Business Insider, and Many More (Sep 24, 2026) · Listen from 53:37
Podcasts
- The Tim Ferriss Show · 1 episode
Episodes
#884: How to Spot 10-Year Trends and Build Billion-Dollar Companies — Kevin Ryan of DoubleClick, MongoDB, Business Insider, and Many MoreThe Tim Ferriss Show · Sep 24, 2026 · 1 h 26 min
Tim Ferriss talks with investor Kevin Ryan about spotting 10-year trends, building DoubleClick, Gilt, Business Insider and MongoDB, psychedelic drug development, deep tech, and immigration.